Punjab Chemicals & Crop Protection Limited — Q3 FY26 earnings call

Call held 29 Jan 2026

Management summary

Punjab Chemicals reported a robust Q3 FY26, with revenue growing 15.3% YoY to INR 246.6 crores and EBITDA surging 53.5% YoY to INR 29.6 crores, driven by product mix and efficiencies despite high fuel costs. The company is strategically investing in new product development, debottlenecking, and new production blocks, with 5-7 new products and 3 MOUs expected to contribute significantly to future revenue. While global agrochemical headwinds persist, management is confident in achieving 15-20% YoY growth and improving EBITDA margins to 15% in the long term.

Highlights

  • Revenue from operations for Q3 FY26 stood at INR 246.6 crores, reflecting a growth of 0.153 year-on-year.

  • EBITDA for Q3 FY26 was INR 29.6 crores, showing a strong growth of 0.535 on a Y-o-Y basis, with an EBITDA margin of 12.0%.

  • Profit after tax for Q3 FY26 grew 127.7% to INR 13.8 crores.

  • New products launched in recent years are contributing significantly and are expected to grow at 0.15 to 0.20 in coming years.

  • Three MOUs signed last quarter are progressing satisfactorily, with commercialization expected in FY27.

Concerns

  • The global agrochemical industry continues to face persistent headwinds, including supply-demand imbalances, channel inventory correction, pricing pressure from Chinese capacity, and volatile raw material costs.

  • Domestic demand remained weak due to weather-related disruptions and lower crop and horticulture prices.

  • Fuel prices (rice husk) continued to be high in Q3, and the shelling for rice was not streamlined, limiting margin recovery from this factor.

Key financials

2 periods

Q3 FY26

  • Revenue
    ₹246.6 Cr
    YoY +15.3%
  • Gross Margin
    41.9%
    YoY +1.9%
  • EBITDA
    ₹29.6 Cr
    YoY +53.5%
  • EBITDA Margin
    12%
  • PAT
    ₹13.8 Cr
    YoY +127.7%
  • PAT Margin
    5.6%

9M FY26

  • Revenue
    ₹821.2 Cr
    YoY +17.6%
  • Gross Margin
    37.7%
  • EBITDA
    ₹90.6 Cr
    YoY +23%
  • EBITDA Margin
    11%
  • PAT
    ₹53 Cr
    YoY +66.2%
  • PAT Margin
    6.5%

What they filed

Q1 FY27: revenue up 8.5%, net profit up 10.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue242 214 201 319 254 +5%246 +15%207 +3%346 +8%
EBITDA26 20 25 34 25 −4%29 +45%27 +8%41 +21%
Net profit12 7 7 20 17 +42%14 +100%10 +43%22 +10%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Capital allocation

high confidence
  • Capex ₹40 Cr
    • Asset renewal and compliance ₹22 Cr
    • Flexibility in production blocks or capacity expansion for new products ₹18 Cr
    • New manufacturing block ₹70 Cr
    So for this year so far, our capex is roughly about INR30 crores. And we will be investing another INR10 crores in the year. So total will be around INR40 crores. Out of this, roughly about INR22 crores is for asset renewal and compliance and other aspects. And about INR18 crores is for creating either a flexibility in production blocks or capacity expansion for the new product that we have added in last 2, 3 years. So that's for this year. I hope that answers your question. FY '27, because our major capital expenditure for the new block will start coming in from March onwards. So we expect the new block to take about INR70 crores. And next year also, we have not done the budgeting exercise, but the capex for asset renewal as well as for capacity expansion or for capability enhancement will be the similar ranges this year.

Guidance & targets

Revenue

  • Revenue growth Revenue · year-on-year · High confidence 15-20%
    overall, I think we continue to grow at 15% to 20% year-on-year, and we continue to maintain that forecast.

    — Vinod Gupta

  • Total revenue post capex completion Revenue · FY27 · High confidence INR 1400-1500 crores
    Given the current price levels, post the completion of capex, suppose if you are talking about FY '27, we should be able to easily do roughly about INR1,400 crores to INR1,500 crores based on the capacity that we are creating.

    — Vinod Gupta

New Products

  • New products contribution to revenue New Products · coming years / next 2 years · High confidence 15-20%

    From 12% (last year) today

    New products launched in recent years are contributing significantly, and these are growing at the rate of 15% to 20% in coming years. ... Last year was about 12%. This year we expect it to be around 15% to 16%. And gradually we will be moving towards 18% to 20% of our business is from the new products that we have introduced in the last 24 months. So that's the kind of metrics that we are targeting.

    — Vinod Gupta

  • Revenue from 5-7 new products New Products · 2-3 years · High confidence INR 150 crores
    Overall, all these 5, 6 products put together, we can expect a contribution in 2 to 3 years of about INR150 crores coming from these new products that we have tried in this year.

    — Vinod Gupta

MOUs

  • Incremental revenue from 3 MOUs MOUs · 3 years (phased in FY27) · High confidence INR 150-180 crores
    So 3 years on the cumulative, so all three together will be INR180 crores on a cumulative basis, right, all three products, three MOUs? Yes, right. ... So far the progress has been that we have actually initial part of the technical due diligence is completed. Our product samples have been approved by the customer. And now we are in the process of final agreement signing where we are now thrashing out final details of the overall arrangement, which is sort of a long-term form agreement with all the three parties, but this will happen in FY '27.

    — Vinod Gupta

EBITDA Margin

  • EBITDA Margin EBITDA Margin · FY26 · High confidence 11.5-12.5%
    I think we will maintain this run rate, and that's the range we are very confident to deliver on a consistent basis.

    — Vinod Gupta

  • EBITDA Margin EBITDA Margin · long term (when revenue reaches INR 1400-1500 crores) · Medium confidence 15%
    And once we probably reach around INR1,400 crores, INR1,500 crores of revenue in next 2 to 3 years, is it safe to assume that we'll go back to 15-odd percent EBITDA margin? Yes. As we have already narrated to you that the newer products is getting better margins. So definitely, the trend of Punjab in terms of gross margin and at the bottom level will definitely improve.

    — Shalil Shroff

Capacity Utilization

  • Lalru capacity utilization Capacity Utilization · 4-6 quarters · High confidence 80%

    From 60-70% today

    So strategically, we are looking at improving Lalru capacity utilization from current levels to healthy levels of about 80%, which should happen in next 4 to 6 quarters.

    — Vinod Gupta

R&D

  • R&D expenditure R&D · next 2 years · High confidence Doubled
    Sir, my question is on the R&D expenditure. It is set to be doubled over the next 2 years.

    — Pratik Shah (analyst, quoting management)

What to watch in Q4 FY26

New Block Capex Progress

Next quarter (Q4 FY26)
Current INR 70 crores capex for new block starting March onwards
Target Progress on construction and spending for the new block

Why it matters

Key to achieving FY27 revenue targets and long-term growth, as it represents a significant capacity addition.

FY '27, because our major capital expenditure for the new block will start coming in from March onwards. So we expect the new block to take about INR70 crores.

Risks & concerns

  • Global Agrochemical Industry Headwinds

    medium

    Persistent headwinds including supply-demand imbalances, channel inventory correction, pricing pressure from Chinese capacity, and volatile raw material costs.

    Management acknowledged

  • Weak Domestic Demand

    medium

    Demand remained weak due to weather-related disruptions and lower crop/horticulture prices.

    Management acknowledged

  • High Fuel Prices

    medium

    Fuel prices (rice husk) continued to be high in Q3, limiting margin recovery from this factor.

    Management acknowledged

  • China Export Policy Changes

    low

    China's withdrawal of export tax rebates for certain pesticides, a potential long-term shift that could eventually benefit the company.

    Management acknowledged, but currently not impacting their products

Q&A highlights

6 direct
Capex Breakdown and Future Revenue Potential Direct
So for this year so far, our capex is roughly about INR30 crores. And we will be investing another INR10 crores in the year. So total will be around INR40 crores. Out of this, roughly about INR22 crores is for asset renewal and compliance and other aspects. And about INR18 crores is for creating either a flexibility in production blocks or capacity expansion for the new product that we have added in last 2, 3 years. ... Given the current price levels, post the completion of capex, suppose if you are talking about FY '27, we should be able to easily do roughly about INR1,400 crores to INR1,500 crores based on the capacity that we are creating.

Provides a clear breakdown of current and future capex plans and links it directly to the company's revenue growth targets for FY27.

Asked by Rahul Jain

New Product Commercialization and Revenue Contribution Direct
As far as the commercialization of these products is concerned, in fact, we are already at the stage of commercializing more products than what we had initially projected. So last quarter, we commercialized one more product. ... So broadly, this year, our new product addition will be in the range of 5 to 7 numbers. ... Overall, all these 5, 6 products put together, we can expect a contribution in 2 to 3 years of about INR150 crores coming from these new products that we have tried in this year.

Details the progress on new product launches, the number of products expected this year, and their anticipated revenue contribution over the next few years.

Asked by Rahul Jain

MOUs Commercialization Timeline and Profitability Direct
MOU, as I mentioned, commercialization, we are expecting in FY '27, not this year. So far the progress has been that we have actually initial part of the technical due diligence is completed. Our product samples have been approved by the customer. ... I think yes. I mean, let's take it to full year because all the three probably will be happening at different stages depending because of the complexity. ... I think that's a fair assumption that these MOUs will be at a higher profitability than the current product basket. And that and these are also sort of exclusive arrangements that we are getting into.

Clarifies the timeline for MOUs commercialization, their expected revenue contribution, and confirms their higher profitability and exclusive nature.

Asked by Rahul Jain

Impact of China Export Tax Rebate Withdrawal on Agrochemical Pricing Partial
Yes, I think this withdrawal of export benefit is on a very selective basis. It is not across the board. It has been product-specific or some particular chapter numbers, which does not cover any of our products at the moment. But our belief is that this is beginning of withdrawal of export and tax benefit by China. ... So at the moment, I mean, if you ask me from 1st April onwards, there will not be our products may not be impacted.

Addresses a key sector-wide concern, indicating that while it's a trend, it doesn't immediately impact Punjab Chemicals' products, but could be a long-term positive.

Asked by Rahul Jain

Drivers of Q3 Margin Recovery Direct
So I think this year, after even after the flood season, because the crop was not good, the fuel prices continue to be high. So we have not seen a significant relief in Q3 and the shelling because we use rice husk as the fuel. ... So whatever improvement you are seeing is mainly attributed to the change in product mix and efficiencies.

Clarifies that margin improvement was due to product mix and efficiencies, not a reduction in high fuel costs, indicating structural improvements rather than external relief.

Asked by Viral Jain

Debottlenecking Impact and Lalru Capacity Utilization Direct
So first is, there will not be any impact on the revenue in Q4. We are expecting this capacity to come back online by mid of February. And this will give a very good incremental revenue for FY '27. ... So strategically, we are looking at improving Lalru capacity utilization from current levels to healthy levels of about 80%, which should happen in next 4 to 6 quarters.

Provides reassurance on Q4 revenue despite debottlenecking and sets a clear target for Lalru plant's capacity utilization, crucial for future growth.

Asked by Viral Jain

Plans for a New Manufacturing Facility Partial
So Jatin, we have already commentated in a couple of our calls, between one and two concalls that we have looked at certain sites. Unfortunately, because of due diligence, it did not fall in place. But at the moment, also we are looking very seriously at 3 sites, which is happening. And as and when it comes in, presumably, I believe that we need a site which is absolutely on our radar. And as and when it happens, we'll definitely inform all of you and including the stock exchange.

Indicates ongoing efforts to expand manufacturing footprint beyond current sites, highlighting a long-term growth driver, despite past challenges in site selection.

Asked by Jatin

Future Domestic vs. Export Mix Direct
So broadly, our share will remain 50-50 even for the new products. But when you look at the number, it will depend on the supply chain, how the customer wants it before the product is placed in the market. But if I look at all the share of the product, it will remain at 50-50 roughly.

Clarifies the expected stability of the domestic-export revenue mix despite evolving supply chain dynamics and new product introductions, providing clarity on market strategy.

Asked by Jatin

2 min read 7 chapters

Detailed narrative

Q3 FY26 Financial Performance Highlights

Punjab Chemicals delivered a strong Q3 FY26, with revenue from operations growing 15.3% year-on-year to INR 246.6 crores. The company's EBITDA for the quarter saw a significant 53.5% increase year-on-year, reaching INR 29.6 crores, translating to a 12.0% EBITDA margin. Profit after tax also surged by 127.7% to INR 13.8 crores, demonstrating robust profitability improvements despite challenging market conditions.

Strategic Focus on Product Innovation and Diversification

The company's strategy emphasizes product innovation and diversification, backed by heavy R&D investments in value-added, non-commodity products. New products launched in recent years are already contributing significantly and are projected to grow at 15-20% annually. Management anticipates that 5-7 new products will collectively add approximately INR 150 crores in revenue over the next 2-3 years, with 3-4 more products scheduled for commercial trials in Q4 FY26.

Capacity Expansion and Operational Efficiency

Punjab Chemicals is actively investing in capacity expansion, including debottlenecking and new production blocks, aligning with the 'Make in India' initiative. The company plans a capex of INR 40 crores for FY26, with INR 22 crores for asset renewal and INR 18 crores for capacity expansion. A major capex of INR 70 crores for a new manufacturing block is set to begin in March 2026. Efforts are also underway to improve Lalru's capacity utilization from 60-70% to a target of 80% within 4-6 quarters.

MOUs and Long-Term Growth Outlook

Three MOUs signed last quarter are progressing well, with commercialization expected in FY27. These MOUs, focused on niche, export-oriented products, are projected to contribute an incremental revenue of INR 150-180 crores over three years and are expected to offer higher profitability. Combined with new product additions and capacity enhancements, the company targets an overall revenue of INR 1400-1500 crores by FY27 and aims for a 15% EBITDA margin in the long term.

Market Headwinds and Margin Management

The global agrochemical industry continues to face headwinds such as supply-demand imbalances, pricing pressure from China, and volatile raw material costs. Domestic demand was also weak due to weather disruptions. Despite these challenges and persistent high fuel prices (rice husk), the company's Q3 margin recovery was primarily driven by a favorable product mix shift and operational efficiencies, rather than external cost relief.

R&D and Backward Integration Initiatives

Punjab Chemicals is committed to doubling its R&D expenditure over the next two years to support new product development and enhance operational efficiencies. The company is also pursuing backward integration, both in-house and through strategic local suppliers, to sustain margins in tough market conditions and mitigate the impact of future price shocks, particularly from China.

New Technology Adoption

The company is expanding its technological capabilities by adding new processes such as hydrogenation, Mercaptan chemistry, and pressure reaction. These new technologies are already being incorporated into the development and production of some of its current products, enhancing its competitive edge and product portfolio.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Chemicals earnings calls